June 14 @ 4:30 pm - 6:30 pmFree
Join us in welcoming Sally Allain, the Head of Johnson & Johnson Innovation – JLABS @ Washington, DC. With experience supporting biotech startups and external partnering for Johnson & Johnson Innovation, Allain will share her insights on the different features and value available at a healthcare and life sciences incubator, including what an application process looks like, what support a startup can expect at different types of accelerators and incubators, and more. She will also share insights into the recent trends that Johnson & Johnson Innovation is seeing for biotech and early-stage companies and how that will impact the industry in 2023. Enjoy an evening of networking, drinks, and fun!
About the Speaker
Sally Allain, MBA, MSc.
Head of Johnson & Johnson Innovation – JLABS @ Washington, DC, and Interim Head, JLABS North East
As Head of JLABS @ Washington, DC, Sally sets the strategic direction and oversees all operational activities for JLABS in the greater Washington metro region, including Maryland and Virginia. In this role, Sally is responsible for the process of evaluating and selecting a strong portfolio of innovators for JLABS @ Washington, DC, and building strategic partnerships with corporate, academic, government and industry organizations that aim to strengthen the region’s life sciences innovation network.